As an internationally operating CDMO, we dedicate our expertise and passion to the manufacture of life-saving biopharmaceuticals, thereby enabling our clients to help patients with rare and serious diseases.
However, we are aware that even the production of the highest-quality biopharmaceuticals has an impact on our environment and society. As a company, we are called upon to take responsibility and do our part to address global challenges, such as climate change.
As a company with a 150-year history, we are committed to this responsibility and have therefore made sustainability an integral part of our corporate strategy.
Through conscious action, we want to create lasting benefits and thus contribute to achieving the 17 Sustainable Development Goals (SDGs) of the United Nations (UN). We focus on the following core topics:
Since its foundation in 2007, EcoVadis has developed into the world's largest and most reliable provider of sustainability ratings for companies with now more than 130,000 rated companies. Since 2021, we have also had our sustainability performance assessed annually by EcoVadis. In 2025, we were once again awarded a silver medal for our commitment to sustainability. Compared to last year, we were able to increase our rating by a further 5 points to 74 points. This puts us among the top 15% of all companies assessed by EcoVadis in the last 12 months and among the top 5% of companies in the “manufacture of basic pharmaceutical products and pharmaceutical preparations” sector. Visit our EcoVadis recognition page here: Ecovadis Silver Medal | RENTSCHLER BIOPHARMA SE
We are pleased to announce that in June 2024, we have joined the UN Global Compact, the world’s largest corporate sustainability initiative. This commitment to responsible business practices aligns with our core values and demonstrates our dedication to upholding the ten principles of the UN Global Compact which cover human and labor rights, environmental protection, and business conduct. Our annual progress report provides a transparent and comprehensive account of our sustainability activities.
Climate protection is a key pillar of our sustainability strategy. To emphasize our efforts, we have had our climate target successfully validated by the Science Based Targets initiative. We are thus committed to making our contribution to meeting the 1.5°C target. Our validated climate target can be viewed at https://sciencebasedtargets.org/companies-taking-action# on the SBTi website. As climate protection organization, the SBTi enables companies and financial institutions worldwide to make their contribution to combating the climate crisis.
Our commitment to sustainability reflects our understanding of the responsibility we hold as a company.
Our sustainability strategy goes far beyond environmental protection and also encompasses social and economic aspects. It is precisely this holistic approach to sustainability that makes our daily work as sustainability officers at Rentschler Biopharma so exciting and diverse. What is particularly important to us is the exchange with our colleagues, because in the end, we can only make a difference together.Miriam Schnösenberg and Maximilian Ludwig, Sustainability Management
Do you have any questions or suggestions about sustainability at Rentschler Biopharma?
